Health Plans Sue Abbott Over Depakote Off-Label Scheme

Law360, New York (August 16, 2013, 5:21 PM EDT) -- Abbott Laboratories Inc. was hit with a proposed class action in Illinois federal court Friday by three health benefit plans alleging it unfairly reaped hundreds of millions of dollars from third-party payors through off-label marketing and kickbacks for prescriptions of anti-seizure medication Depakote.

According to the plaintiffs — Sidney Hillman Health Center of Rochester, Teamsters Health Services and Insurance Plan Local 404 and United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund — Abbott's misbranding scheme had resulted in private payors reimbursing many off-label Depakote prescriptions when their beneficiaries would have otherwise been prescribed more appropriate medications....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!